Hepatitis B and Hepatitis C: Symptoms, Viral Load, Liver Damage, Treatment, Cure and Prevention in Agra
हेपेटाइटिस B और C क्या हैं? क्या ये पूरी तरह ठीक होते हैं? वायरल लोड कितना होना चाहिए? और लिवर को कैसे बचाया जा सकता है?
Prepared for Dr. Karan R. Rawat
MBBS, MS, FIAGES, FMAS, DMAS, FICRS, FALS, FISCP, FAIAS, MCLS, FCLS
Gastrointestinal & Hepatobiliary Surgery | Liver, Gallbladder & Pancreatic Conditions | Laparoscopic & Advanced Surgery
Safe Gastro & Surgery Center
Within Agra Heart Centre Complex, Church Road, Civil Lines, Agra, Uttar Pradesh
Two Patients. Two Positive Reports. Two Very Different Treatment Journeys.
Imagine two patients visiting a gastrointestinal clinic.
A 32-year-old man undergoes routine blood investigations and discovers that his HBsAg is positive.
His liver function tests are normal, and he has no symptoms.
Naturally, he asks:
“Doctor, do I have Hepatitis B? Is it curable? Will I need medicines for the rest of my life?”
Another patient, a 46-year-old woman, discovers that her anti-HCV antibody test is positive.
She has been feeling healthy for years.
She asks:
“Doctor, is this Hepatitis C? Can medicines completely remove the virus? Will my family also become infected?”
Both patients may have viral hepatitis.
Both may have normal liver function tests.
Both may have no visible jaundice.
But the diagnostic approach, treatment decisions and long-term management are different.
Hepatitis B can often be suppressed effectively with antiviral medicines and can be prevented through vaccination. Hepatitis C can usually be cured with a short course of modern antiviral medicines, but no effective vaccine is currently available.
Understanding these differences is essential for protecting the liver and avoiding unnecessary fear.
1. What Are Hepatitis B and Hepatitis C?
Hepatitis means inflammation of the liver.
Hepatitis B and Hepatitis C are viral infections caused by two different viruses:
- HBV: Hepatitis B virus
- HCV: Hepatitis C virus
Both viruses can damage liver cells and produce inflammation.
In some patients, the infection is cleared by the immune system.
In others, it persists and becomes chronic.
Long-standing infection may lead to progressive liver scarring, also called fibrosis.
Advanced scarring can progress to cirrhosis, which may eventually cause liver failure or increase the risk of liver cancer.
However, chronic infection does not mean that every patient will develop cirrhosis or cancer.
Early diagnosis, appropriate treatment and follow-up can substantially improve outcomes.
2. Hepatitis B vs Hepatitis C: Important Differences
| Feature | Hepatitis B | Hepatitis C |
|---|---|---|
| Virus | HBV | HCV |
| Main transmission | Blood, sexual exposure, childbirth | Primarily infected blood |
| Vaccine | Available | No effective vaccine |
| Initial screening | HBsAg with other HBV markers | Anti-HCV antibody |
| Viral load test | HBV DNA PCR | HCV RNA PCR |
| Chronic infection | May require long-term monitoring or treatment | Usually offered curative antiviral treatment |
| Common treatment | Tenofovir or entecavir in appropriate patients | Direct-acting antiviral combinations |
| Complete cure | Uncommon in chronic HBV | Achievable in more than 95% of treated people |
| Liver cirrhosis risk | Yes | Yes |
| Liver cancer risk | Yes | Yes |
| Normal ALT possible? | Yes | Yes |
| Asymptomatic infection possible? | Yes | Yes |
A normal liver function test does not reliably exclude either infection or significant liver fibrosis.
3. How Common Are Hepatitis B and Hepatitis C?
According to the World Health Organization’s July 2026 fact sheets:
- Approximately 240 million people worldwide were living with chronic Hepatitis B in 2024.
- Approximately 47 million people worldwide were living with chronic Hepatitis C.
- Both infections contribute to substantial illness and mortality from liver cirrhosis and hepatocellular carcinoma.
One of the biggest challenges is that many infected individuals remain unaware of their condition.
They may discover the infection only during blood donation screening, pregnancy testing, preoperative investigations, health check-ups or evaluation of abnormal liver tests.
Hepatitis B and C are often silent infections, which is why appropriate testing matters even in patients who feel healthy.
4. How Do Hepatitis B and C Spread?
Understanding transmission is important for both prevention and reducing unnecessary stigma.
Hepatitis B transmission
Hepatitis B can spread through infected blood and certain body fluids.
Important routes include:
- Transmission from an infected mother to her baby during birth
- Unprotected sexual contact
- Sharing contaminated needles or syringes
- Unsafe medical, dental or injection procedures
- Accidental needlestick injuries
- Sharing razors or toothbrushes contaminated with blood
- Tattooing or piercing using inadequately sterilised instruments
Hepatitis C transmission
Hepatitis C is primarily transmitted through blood exposure.
Important routes include:
- Reuse of needles or syringes
- Unsafe medical procedures
- Sharing injection equipment
- Unscreened blood products
- Tattooing or piercing with non-sterile instruments
- Sharing personal items contaminated with blood
Hepatitis C can sometimes spread through sexual exposure or from mother to baby, but these routes are less efficient than for Hepatitis B.
How do these infections NOT spread?
Hepatitis B and C are not transmitted through ordinary social contact such as:
- Hugging
- Shaking hands
- Sitting together
- Sharing a meal
- Sharing ordinary utensils
- Coughing or sneezing
- Drinking water from the same source
- Using the same workplace or classroom
Routine kissing is not a recognised transmission route in the absence of blood exposure.
A person with Hepatitis B or C does not need to be socially isolated.
5. What Are the Symptoms of Hepatitis B and Hepatitis C?
Many patients experience no symptoms during the initial or chronic stages.
When symptoms do occur, they may include:
- Tiredness and weakness
- Reduced appetite
- Nausea or vomiting
- Upper abdominal discomfort
- Fever during acute infection
- Joint or muscle pain
- Yellowing of the eyes or skin
- Dark urine
- Pale stools
In advanced liver disease, patients may experience abdominal swelling, leg swelling, gastrointestinal bleeding, weight loss or mental confusion.
These later symptoms require urgent medical evaluation.
Can Hepatitis B or C occur without jaundice?
Yes.
A patient can have chronic Hepatitis B or C for years without yellow eyes or other obvious symptoms.
Waiting for jaundice before testing can delay diagnosis.
6. Acute Hepatitis vs Chronic Hepatitis: What Is the Difference?
Acute hepatitis
Acute viral hepatitis is a recent infection.
In adults, newly acquired Hepatitis B often clears spontaneously.
Some patients with acute Hepatitis C also clear the virus naturally, but modern guidelines generally support offering treatment to patients with confirmed active HCV rather than relying on spontaneous clearance.
Chronic hepatitis
Hepatitis B is generally considered chronic when HBsAg remains positive for at least six months.
Hepatitis C is considered chronic when infection persists beyond approximately six months, although treatment does not need to be delayed until this time if active infection is confirmed.
Chronic infections may require evaluation for fibrosis, cirrhosis and other liver complications.
7. HBsAg Positive: Does It Mean Hepatitis B?
HBsAg stands for Hepatitis B Surface Antigen.
It is an important screening marker.
When HBsAg is confirmed positive, it generally indicates current Hepatitis B infection.
However, HBsAg positivity alone does not determine:
- Whether infection is acute or chronic
- Whether antiviral treatment is immediately required
- How much liver damage has occurred
- The likelihood of transmission in a particular situation
- Whether cirrhosis is present
Further assessment is required.
What additional tests may be needed?
An appropriate evaluation can include:
- HBV DNA quantitative PCR
- HBeAg and anti-HBe
- ALT, AST and other liver tests
- CBC and platelet count
- Albumin and PT/INR
- Ultrasound liver
- FibroScan or other fibrosis assessment
- Anti-HDV testing
- Relevant HIV and HCV screening
Some patients also need evaluation for hepatitis A immunity and vaccination status.
The exact tests depend on the clinical presentation.
8. Understanding Hepatitis B Blood Test Results
| Test | Main purpose |
|---|---|
| HBsAg | Detects current HBV infection |
| Anti-HBs | Helps assess immunity after vaccination or recovery |
| Total anti-HBc | Indicates previous or ongoing natural HBV exposure |
| IgM anti-HBc | Helps identify recent infection; may also rise during a flare |
| HBeAg | Marker associated with viral replication |
| Anti-HBe | Helps assess infection phase |
| HBV DNA PCR | Measures viral replication |
| ALT/AST | Assess liver injury, not necessarily liver function |
| Albumin/PT-INR | Help assess liver synthetic function |
| FibroScan | Helps estimate liver stiffness and fibrosis |
What does HBeAg negative mean?
HBeAg negativity does not automatically mean the virus is inactive.
Some patients have HBeAg-negative chronic hepatitis with significant HBV replication and liver inflammation.
This is why HBV DNA, ALT and fibrosis assessment remain important.
What does anti-HBs positive mean?
Anti-HBs positivity often indicates immunity from vaccination or previous infection.
A post-vaccination anti-HBs concentration of at least 10 mIU/mL is commonly considered protective when measured at the appropriate time following a completed vaccine series.
Interpretation depends on vaccination history and the other HBV markers.
What if only anti-HBc is positive?
An isolated positive anti-HBc result may reflect previous infection, a false-positive result or occasionally occult infection.
It should not automatically be interpreted as active chronic Hepatitis B.
9. HBV DNA Viral Load: What Does It Mean and Why Is It Important?
One of the most searched questions is:
“Hepatitis B viral load kitna hona chahiye?”
HBV DNA PCR measures the amount of viral genetic material circulating in the blood.
Results are commonly reported in IU/mL.
For example, a laboratory might report:
- HBV DNA not detected
- HBV DNA 500 IU/mL
- HBV DNA 5,000 IU/mL
- HBV DNA 100,000 IU/mL
- HBV DNA 1,000,000 IU/mL
These are illustrative results, not universal categories of safety or danger.
Why is viral load measured?
HBV DNA helps the clinician:
- Confirm and assess viral replication.
- Determine treatment eligibility along with other clinical findings.
- Monitor the response to antiviral treatment.
- Identify possible virologic breakthrough.
- Assess special transmission risks, including during pregnancy.
Does a high viral load always mean severe liver damage?
No.
A person may have a high HBV DNA level with relatively normal liver enzymes.
Another patient with a lower viral load may have substantial fibrosis or cirrhosis.
Viral load must therefore be interpreted with ALT, fibrosis stage, age, medical history and other risk factors.
What if HBV DNA is undetectable?
This is often a favourable finding, especially during successful antiviral treatment.
However, undetectable HBV DNA does not automatically mean the virus has been eliminated from the body.
Chronic HBV can persist in liver cells even when circulating viral DNA is not detectable.
Undetectable HBV DNA is not the same as a complete cure.
10. When Should Hepatitis B Treatment Be Started?
Not every person with a positive HBsAg test requires immediate lifelong antiviral treatment.
Treatment eligibility is assessed using several factors, including:
- Presence of cirrhosis or significant liver fibrosis
- HBV DNA levels
- ALT levels and evidence of liver inflammation
- Age
- Family history of liver cancer or cirrhosis
- HIV, HCV or hepatitis D coinfection
- Immunosuppression and risk of HBV reactivation
- Pregnancy and risk of mother-to-child transmission
- Other individual medical factors
WHO’s 2024 guidance expanded treatment eligibility, and AASLD released updated chronic Hepatitis B treatment guidance in 2025.
Commonly used Hepatitis B medicines
First-line antiviral options include:
Tenofovir disoproxil fumarate (TDF)
Tenofovir alafenamide (TAF)
Entecavir
The precise choice depends on the patient’s age, kidney health, bone health, pregnancy status, HIV status, previous antiviral treatment and other factors.
These medicines suppress viral replication and can reduce the risk of progressive liver disease.
Is Hepatitis B treatment lifelong?
Many patients require long-term treatment, sometimes indefinitely.
However, treatment duration is individualised.
Patients should never stop an HBV antiviral medicine without specialist advice because stopping treatment can lead to serious hepatitis flares.
11. Can Hepatitis B Be Completely Cured?
This is one of the most important differences between Hepatitis B and Hepatitis C.
For established chronic Hepatitis B, currently available oral antiviral medicines generally suppress the virus rather than eradicate it completely.
A small proportion of patients achieve loss of HBsAg, sometimes called a functional cure.
This is different from complete eradication of all viral material from liver cells.
Research into more effective curative treatments continues.
What is the practical goal of treatment?
The primary objectives are to:
- Suppress viral replication
- Reduce liver inflammation
- Prevent or slow fibrosis progression
- Reduce the risk of cirrhosis
- Reduce the risk of liver cancer
- Improve long-term survival
Patients should understand that effective disease control is a meaningful medical outcome even when complete viral eradication is not possible.
12. Hepatitis C: Why Is It Often Called a Curable Infection?
Hepatitis C treatment has changed dramatically.
Older interferon-based treatments were difficult for many patients because of prolonged therapy and significant side effects.
Modern treatment uses direct-acting antiviral medicines (DAAs).
These drugs target essential steps in the Hepatitis C viral life cycle.
Most patients can now be treated using oral medicines without interferon.
Commonly used HCV antiviral combinations
Examples include:
- Sofosbuvir + velpatasvir
- Glecaprevir + pibrentasvir
- Sofosbuvir + daclatasvir in appropriate settings
Treatment selection depends on liver function, cirrhosis status, previous treatment, potential drug interactions, kidney function and other clinical considerations.
Many uncomplicated cases can be treated in approximately 8–12 weeks. Some patients require longer or more specialised regimens.
More than 95% of treated patients can achieve virologic cure with modern DAA therapy.
This is a major advance in liver medicine.
13. Anti-HCV Positive: Does It Mean Active Hepatitis C?
Not always.
An anti-HCV antibody test identifies antibodies produced after exposure to Hepatitis C.
A positive result may mean:
- Current Hepatitis C infection
- Previously resolved infection
- Successfully treated infection
- Occasionally, a false-positive screening result
The antibody result alone does not establish current active infection.
Why is HCV RNA PCR necessary?
HCV RNA PCR detects viral genetic material in the blood.
If HCV RNA is detected, current infection is present.
If anti-HCV is positive but HCV RNA is not detected, there is generally no evidence of current infection, although repeat testing may be needed after recent exposure or in selected situations.
The key diagnostic rule
Anti-HCV antibody positive → Confirm with HCV RNA testing.
Starting treatment without confirming current HCV infection would be inappropriate.
14. HCV Viral Load: Is a Higher Number More Dangerous?
HCV viral load measures the amount of Hepatitis C RNA in the blood.
It helps establish current infection and provides a baseline for treatment.
However, HCV RNA level does not reliably indicate how much liver scarring has occurred.
A person with a high viral load may have limited fibrosis.
Another patient with a lower viral load may have advanced liver disease.
Does HCV viral load determine whether treatment is needed?
In most cases, confirmed active HCV infection is an indication to assess and offer antiviral treatment.
The decision is not based solely on whether the HCV RNA value is high or low.
What does HCV RNA not detected after treatment mean?
The standard measure of successful treatment is an undetectable HCV RNA result at least 12 weeks after completing antiviral medicines.
This is called Sustained Virologic Response at 12 weeks (SVR12).
SVR12 is regarded as virologic cure.
However, curing HCV does not produce immunity against future reinfection.
15. Can Hepatitis B or C Cause Cirrhosis and Liver Cancer?
Yes.
Persistent inflammation may gradually produce liver fibrosis.
Fibrosis can progress to cirrhosis.
Cirrhosis can lead to:
- Ascites or abdominal fluid accumulation
- Portal hypertension
- Esophageal or gastric varices
- Gastrointestinal bleeding
- Hepatic encephalopathy
- Liver failure
- Hepatocellular carcinoma
Hepatitis B can increase liver cancer risk even in some people who have not developed cirrhosis.
In Hepatitis C, the presence of cirrhosis is a major determinant of continuing cancer risk.
Is liver cancer screening required?
Selected patients with chronic Hepatitis B or cirrhosis require liver cancer surveillance.
Depending on risk, this commonly involves ultrasound examination approximately every six months, sometimes combined with alpha-fetoprotein (AFP).
Patients with HCV-related cirrhosis generally continue surveillance even after successful antiviral treatment.
A cured infection and a fully healed liver are not always the same thing.
16. What Is FibroScan and Why Is It Useful?
FibroScan is a non-invasive test that estimates liver stiffness.
It helps assess the likelihood of liver fibrosis.
The clinician may also use blood-based scores such as FIB-4 or APRI.
These investigations can help identify patients who need more intensive monitoring or specialist management.
Does a normal ultrasound exclude fibrosis?
No.
Ultrasound can detect some structural changes associated with advanced liver disease, but it may not identify early fibrosis.
Normal imaging does not always mean the liver is completely healthy.
Is a liver biopsy always necessary?
No.
Modern non-invasive tests have reduced the need for liver biopsy in many patients.
A biopsy may still be useful when the diagnosis or fibrosis assessment remains uncertain.
17. Hepatitis B and Pregnancy: Can the Baby Be Protected?
Yes. Effective prevention strategies are available.
Pregnant women should undergo appropriate Hepatitis B screening.
If the mother is HBsAg positive, HBV DNA testing helps assess the risk of transmission to the baby.
In women with a high viral load, typically at or above 200,000 IU/mL, antiviral prophylaxis with tenofovir may be recommended during late pregnancy under obstetric and specialist supervision.
What should happen after delivery?
A baby born to an HBsAg-positive mother requires timely preventive care.
This usually includes:
- Hepatitis B vaccine as soon as possible after birth
- Hepatitis B immune globulin (HBIG), where indicated and available, ideally within 12 hours
- Completion of the full vaccination series
- Post-vaccination testing at the recommended age
For infants born to infected mothers, prevention should be coordinated before delivery so the birth facility is prepared.
Can an HBsAg-positive mother breastfeed?
Breastfeeding is generally compatible with Hepatitis B when appropriate infant immunoprophylaxis is provided.
If nipples are cracked or bleeding, temporary precautions and medical advice are appropriate.
18. Hepatitis C and Pregnancy: What Is Different?
Hepatitis C can sometimes pass from an infected mother to her baby.
There is currently no Hepatitis C vaccine or equivalent routine newborn immune globulin protection.
Women with active Hepatitis C who are planning pregnancy may benefit from antiviral treatment before conception.
Management during an established pregnancy requires specialist assessment because experience with routine DAA use in pregnancy remains more limited than in non-pregnant adults.
Babies exposed during pregnancy should receive appropriate HCV testing and follow-up.
Breastfeeding is generally permitted unless nipples are cracked or bleeding.
19. Can Hepatitis B and Hepatitis C Patients Get Married and Have Children?
Yes.
A Hepatitis B or Hepatitis C diagnosis does not automatically prevent marriage, family life or pregnancy.
However, preventive counselling and appropriate medical care are important.
For Hepatitis B
The partner should be tested for infection and immunity.
A susceptible partner should receive Hepatitis B vaccination.
Appropriate precautions are advised until protection is established.
For Hepatitis C
The infected person should be evaluated for curative treatment.
Partners may need testing depending on risk and clinical history.
HCV transmission through sexual contact is generally less efficient than HBV transmission, but risk is not zero.
What about confidentiality and stigma?
Patients deserve privacy, accurate information and respectful care.
Neither infection is spread through ordinary family interaction.
Fear of social rejection should not prevent patients from getting tested or treated.
20. Can Hepatitis B or C Reactivate?
Hepatitis B can reactivate in people with current or previous infection, particularly during certain immunosuppressive treatments.
Examples include selected cancer therapies, high-intensity immune suppression and some biological medicines.
Patients should inform their treating doctor of previous HBV infection before such treatment.
What about Hepatitis C treatment?
In people who have both HBV and HCV, treatment for HCV can sometimes be associated with HBV reactivation.
That is why HBV screening is important before initiating HCV direct-acting antivirals.
Monitoring or antiviral prophylaxis may be needed according to the clinical risk.
21. Is Hepatitis D Important in an HBsAg-Positive Patient?
Yes.
Hepatitis D virus (HDV) can infect only people who also have Hepatitis B infection.
HBV-HDV coinfection can increase the risk of serious liver disease.
WHO recommends broadening anti-HDV screening among HBsAg-positive patients, ideally including all where feasible.
A positive anti-HDV test may need confirmation of active infection with HDV RNA.
This is an important consideration when liver inflammation seems disproportionate to the HBV DNA level.
22. What Should Hepatitis B and C Patients Eat?
No special food can eradicate HBV or HCV.
Nutrition supports liver health but cannot replace antiviral treatment.
A balanced Indian diet may include:
- Roti, rice and whole grains
- Dal and other pulses
- Adequate protein
- Seasonal vegetables
- Washed fruits
- Suitable milk, curd or other dairy
- Appropriate healthy fats
- Adequate hydration
Should patients avoid protein?
Not routinely.
Patients with chronic liver disease often need careful attention to adequate protein and calorie intake.
Unnecessary protein restriction may worsen malnutrition.
Is sugarcane juice a cure?
No.
Sugarcane juice cannot cure Hepatitis B or C or reduce viral load in a clinically reliable way.
What about alcohol?
Avoiding alcohol is strongly advisable because alcohol can worsen liver damage.
Are herbal liver tonics useful?
Unregulated herbal medicines and so-called liver detox supplements are not established treatments for viral hepatitis.
Some can cause serious liver injury or interfere with prescribed medicines.
Can patients exercise?
Most clinically stable patients can remain physically active.
Exercise recommendations should be adapted for those with acute severe illness, advanced cirrhosis or other complications.
23. When Is Hepatitis B or C an Emergency?
Seek urgent hospital assessment for:
- New confusion or unusual drowsiness
- Vomiting blood
- Black, tarry stools
- Severe jaundice with marked illness
- New abdominal swelling with fever or pain
- Significant bleeding or bruising
- Persistent vomiting or dehydration
- Rapid clinical deterioration
These signs may reflect severe liver dysfunction or another important complication.
Routine outpatient appointments should not delay emergency treatment.
24. Hepatitis B and Hepatitis C Consultation in Agra
Patients with a positive HBsAg test, reactive anti-HCV result, detectable viral load or abnormal liver tests need an appropriate clinical assessment.
A meaningful evaluation involves more than looking at whether the test is simply positive or negative.
The objective is to determine:
- Whether active infection is present.
- Whether infection is acute or chronic.
- How the liver is functioning.
- Whether fibrosis or cirrhosis is present.
- Whether antiviral treatment is indicated.
- Whether liver cancer surveillance or specialist referral is needed.
- How to protect family members and prevent further transmission.
Dr. Karan R. Rawat provides gastrointestinal and surgical consultation in Agra, with a professional focus that includes liver, gallbladder, pancreatic, gastrointestinal and hepatobiliary surgical conditions.
Patients requiring specialised antiviral treatment, advanced liver disease care or transplant evaluation should receive appropriate medical hepatology or multidisciplinary care as indicated.
Clinic details
Dr. Karan R. Rawat
MBBS, MS, FIAGES, FMAS, DMAS, FICRS, FALS, FISCP, FAIAS, MCLS, FCLS
Safe Gastro & Surgery Center
Within Agra Heart Centre Complex
Church Road, Civil Lines, Agra, Uttar Pradesh, India
Serving Agra and Surrounding Regions
This guide is intended for patients searching for liver and hepatitis-related healthcare information in:
Agra: Civil Lines, Kamla Nagar, Dayalbagh, Sikandra, Shahganj, Tajganj, Etmadpur, Fatehabad, Fatehpur Sikri and Kheragarh.
Nearby Uttar Pradesh: Mathura, Firozabad, Tundla, Shikohabad, Hathras, Etah, Mainpuri and Aligarh.
Nearby Rajasthan and Madhya Pradesh: Bharatpur, Dholpur, Morena and neighbouring accessible areas.
These are regional patient-search locations, not additional clinic branches.
25. Complete Patient FAQ: 65 Commonly Searched Questions About Hepatitis B and Hepatitis C
The following questions reflect common patient search intentions in English, Hindi and Hinglish. They are grouped to help people understand reports, treatment, family concerns, prevention and long-term liver care.
A. Basic Questions: Hepatitis B vs Hepatitis C
Q1. What is Hepatitis B?
Hepatitis B is a viral infection affecting the liver. It may be acute or chronic and can cause liver inflammation, fibrosis, cirrhosis and liver cancer.
Q2. What is Hepatitis C?
Hepatitis C is a bloodborne viral infection of the liver. It may become chronic but can usually be cured with modern antiviral medicines.
Q3. Which is more dangerous: Hepatitis B or Hepatitis C?
Both can cause serious liver disease. Hepatitis B is vaccine-preventable but is usually not completely curable once chronic. Hepatitis C has no vaccine but can usually be cured. Individual risk depends on liver damage and other clinical factors.
Q4. Can Hepatitis B and C occur without symptoms?
Yes. Many patients remain asymptomatic for years despite ongoing viral infection.
Q5. Does every Hepatitis B or C patient develop jaundice?
No. Many patients never develop visible jaundice, even with chronic infection.
Q6. What is chronic Hepatitis B?
It generally means persistence of HBsAg for at least six months.
Q7. What is chronic Hepatitis C?
It means persistent HCV infection beyond approximately six months, although active HCV can be treated earlier.
Q8. Can Hepatitis B or C cause fatty liver?
Viral hepatitis and metabolic fatty liver disease can coexist. They are different conditions and should be evaluated separately.
Q9. Can someone with hepatitis live a normal life?
Yes. Many patients live active lives with appropriate treatment, monitoring and preventive care. Prognosis depends partly on the stage of liver disease.
Q10. Can hepatitis cause liver cancer?
Yes. Chronic HBV and HCV are important risk factors for hepatocellular carcinoma, particularly when advanced liver disease is present.
B. Blood Tests, PCR and Viral Load Questions
Q11. My HBsAg is positive. What should I do?
Arrange medical evaluation and confirmation as appropriate. Further tests may include HBV DNA, liver profile, HBeAg and fibrosis assessment. Do not begin or stop antiviral medicines on your own.
Q12. Is HBsAg positive always dangerous?
No. It indicates a possible current HBV infection that needs assessment, but the level of immediate risk varies substantially.
Q13. What does HBsAg negative mean?
It usually means no detectable surface antigen at the time of testing. Other markers and exposure history may be needed to establish whether you are susceptible, vaccinated or previously infected.
Q14. What are the three main Hepatitis B screening tests?
HBsAg, anti-HBs and total anti-HBc. Together they help distinguish current infection, previous infection, vaccine-related immunity and susceptibility.
Q15. What does anti-HBs above 10 mean?
When measured after an appropriately completed vaccine series, an anti-HBs level of at least 10 mIU/mL generally indicates a protective response.
Q16. What if anti-HBc is positive but HBsAg is negative?
It may indicate past resolved infection or another situation requiring interpretation. The other markers and clinical history determine next steps.
Q17. What does HBeAg positive mean?
It is usually associated with active viral replication and often higher infectivity, but HBV DNA provides a more direct measurement of viral replication.
Q18. Is HBeAg negative the same as inactive Hepatitis B?
No. Some HBeAg-negative patients have active hepatitis and significant viral replication.
Q19. What is HBV DNA PCR?
It is a molecular test measuring Hepatitis B viral genetic material in the blood, usually reported in IU/mL.
Q20. Hepatitis B viral load kitna hona chahiye?
There is no single safe viral-load value applicable to every patient. Treatment decisions depend on HBV DNA together with ALT, fibrosis, cirrhosis and other clinical factors.
Q21. Is HBV DNA 2,000 IU/mL dangerous?
It is a clinically relevant threshold in some treatment algorithms but does not independently determine danger. The overall liver assessment is essential.
Q22. Is HBV DNA 100,000 IU/mL very serious?
It indicates substantial viral replication, but the degree of liver injury cannot be determined from this number alone.
Q23. Is undetectable HBV DNA equivalent to cure?
No. The virus may persist within liver cells, and continued monitoring may be necessary.
Q24. Can ALT/SGPT be normal despite Hepatitis B or C?
Yes. Normal ALT does not exclude current infection, significant fibrosis or all forms of liver injury.
Q25. What does anti-HCV positive mean?
It indicates antibodies against Hepatitis C and may represent current infection, past resolved infection or previous successful treatment. HCV RNA is needed to confirm current infection.
Q26. What if anti-HCV is positive but HCV RNA is negative?
There is generally no evidence of current infection. Retesting may be necessary after recent exposure or in selected circumstances.
Q27. Does anti-HCV remain positive after cure?
Yes. Anti-HCV antibodies usually remain detectable after successful antiviral treatment.
Q28. What is HCV RNA PCR?
It detects the genetic material of Hepatitis C virus and confirms current infection when positive.
Q29. Is a high Hepatitis C viral load more dangerous?
Not necessarily. HCV RNA level does not reliably measure the severity of fibrosis or cirrhosis.
Q30. When should testing be done after possible exposure?
Timing depends on the infection and the type of test. HCV RNA may become detectable within roughly 1–2 weeks, while antibodies usually take longer. Recent HBV exposure requires prompt assessment for post-exposure prophylaxis, not simply delayed testing.
C. Treatment, Medicines and Cure
Q31. Is Hepatitis B completely curable?
Established chronic Hepatitis B usually cannot be eradicated with currently available medicines, but viral replication can often be suppressed effectively.
Q32. Which medicines are used for chronic Hepatitis B?
Common options include tenofovir disoproxil fumarate, tenofovir alafenamide and entecavir when clinically indicated.
Q33. Does everyone with positive HBsAg need medicines?
No. Treatment eligibility depends on liver inflammation, fibrosis, cirrhosis, viral load and individual risk factors.
Q34. Is Hepatitis B treatment lifelong?
Often, but not always. Treatment duration and any decision to stop medicines require specialist assessment and monitoring.
Q35. Can I stop tenofovir if my viral load becomes negative?
Not without medical supervision. Stopping treatment can result in viral reactivation or a severe hepatitis flare.
Q36. Is Hepatitis C completely curable?
Yes. Modern direct-acting antiviral medicines achieve virologic cure in more than 95% of treated patients.
Q37. How long does Hepatitis C treatment take?
Many uncomplicated infections are treated in approximately 8–12 weeks, while some situations require longer or specialised treatment.
Q38. Does Hepatitis C still require interferon injections?
Usually not. Modern oral direct-acting antiviral medicines have largely replaced interferon-based treatment.
Q39. How do I know if Hepatitis C is cured?
A negative HCV RNA test at least 12 weeks after completing treatment confirms SVR12, the standard definition of virologic cure.
Q40. Can Hepatitis C return after cure?
Reinfection is possible if a person is exposed to the virus again. True late relapse after confirmed SVR12 is uncommon.
Q41. Is Hepatitis C genotype testing always required?
No. Many modern antiviral regimens are pangenotypic, although genotype or resistance testing may still be important for selected treatment decisions.
Q42. Can a patient with cirrhosis take Hepatitis C medicines?
Often yes, but the regimen must be selected carefully. Certain antiviral combinations are unsuitable for decompensated cirrhosis.
Q43. Does curing Hepatitis C remove liver cancer risk?
It substantially reduces risk, but patients with cirrhosis may still require long-term cancer surveillance.
Q44. Can a person have Hepatitis B and Hepatitis C together?
Yes. Coinfection is possible and requires careful evaluation because treatment and monitoring are more complex.
Q45. What is Hepatitis D and who should be tested?
Hepatitis D is another viral infection that requires Hepatitis B infection to exist. Anti-HDV screening is recommended or considered for HBsAg-positive patients according to current guidance and availability.
D. Family, Marriage, Pregnancy and Transmission
Q46. Does Hepatitis B spread through food or water?
No. Hepatitis B is not a foodborne or waterborne infection.
Q47. Does Hepatitis C spread by eating together?
No. Sharing normal meals or utensils does not transmit Hepatitis C.
Q48. Can Hepatitis B or C spread through kissing?
Ordinary kissing is not a recognised route of transmission. Avoid blood exposure when there are bleeding oral wounds.
Q49. Can Hepatitis B spread through sexual contact?
Yes. Sexual transmission is an important route. Testing, vaccination of susceptible partners and suitable protection are recommended.
Q50. Can a person with Hepatitis B or C get married?
Yes. Marriage is not contraindicated. Honest communication, appropriate testing and prevention are important.
Q51. Can a man with Hepatitis B become a father?
Yes. Hepatitis B does not automatically prevent fatherhood. The partner should be screened and vaccinated if susceptible.
Q52. Can an HBsAg-positive woman have a healthy baby?
Yes. Appropriate maternal assessment, antiviral prophylaxis when indicated and timely newborn immunoprophylaxis can greatly reduce transmission risk.
Q53. Can a woman with Hepatitis C become pregnant?
Yes. When feasible, curative HCV treatment before pregnancy may simplify management and reduce transmission risk.
Q54. Can mothers with Hepatitis B or C breastfeed?
Generally yes, with appropriate precautions. Babies exposed to HBV require recommended immunoprophylaxis. Cracked or bleeding nipples require temporary precautions.
Q55. How can Hepatitis B transmission to a newborn be prevented?
Timely Hepatitis B vaccination, HBIG where indicated, completion of the vaccine series and maternal antiviral treatment when appropriate.
Q56. Can mosquitoes spread Hepatitis B or C?
These viruses are not recognised as being transmitted through mosquito bites.
Q57. Can contaminated tattoo, piercing or barber instruments spread hepatitis?
Yes, particularly when equipment contaminated with blood is reused without proper sterilisation.
Q58. Can a blood transfusion cause hepatitis?
Historically, unscreened blood was an important source. Appropriate donor screening and modern blood-bank practices substantially reduce this risk.
Q59. Is there a vaccine for Hepatitis B?
Yes. Safe and effective Hepatitis B vaccination is available. The schedule depends on age, previous doses and clinical circumstances.
Q60. Is there a vaccine for Hepatitis C?
No effective Hepatitis C vaccine is currently available.
E. Daily Life, Diet, Prevention and Cost
Q61. Can hepatitis patients eat normal Indian food?
Most stable patients can follow a balanced diet containing grains, pulses, vegetables, fruits and adequate protein. Advanced liver disease may require individualised nutrition.
Q62. Can alcohol or herbal liver tonics worsen hepatitis?
Yes. Alcohol can worsen liver injury, and some unregulated herbal preparations can be hepatotoxic. Neither should replace antiviral treatment.
Q63. Can a hepatitis patient exercise or go to the gym?
Many stable patients can exercise, but activity should be tailored to symptoms, liver function and complications.
Q64. Can someone with Hepatitis B or C work in an office, school or normal workplace?
Usually yes. Ordinary workplace interactions do not transmit the infection. Special infection-control rules may apply to certain exposure-prone healthcare procedures.
Q65. Is free Hepatitis B or C treatment available in India?
India’s National Viral Hepatitis Control Programme aims to provide free screening, diagnosis and treatment through public-sector services in a phased manner. Availability should be confirmed with the relevant participating centre.
26. Important Myths and Facts
Myth: HBsAg positive means immediate liver failure.
Fact: It indicates possible current HBV infection requiring assessment, not automatic liver failure.
Myth: Hepatitis C antibody positive means lifelong infection.
Fact: HCV RNA testing is necessary to determine current infection, and modern treatment can cure most active infections.
Myth: Viral load alone determines liver damage.
Fact: Fibrosis, cirrhosis, liver tests and other risk factors must also be considered.
Myth: Hepatitis B spreads by sharing food.
Fact: It is not transmitted by ordinary shared meals.
Myth: Hepatitis C has no effective treatment.
Fact: Modern oral medicines cure more than 95% of treated patients.
Myth: If SGPT is normal, the liver must be healthy.
Fact: Normal liver enzymes do not exclude chronic infection or fibrosis.
Myth: After Hepatitis C treatment, there is never any need for follow-up.
Fact: Patients with cirrhosis may need continuing surveillance even after cure.
Myth: Hepatitis B and C can be cured by sugarcane juice or herbal liver cleansing.
Fact: These do not eradicate the viruses or replace evidence-based treatment.
27. Final Message: Don’t Fear the Positive Report — Understand What It Means
A positive hepatitis screening result can cause anxiety, especially when patients search online for information about liver failure, cancer, transmission or lifelong treatment.
But the first priority is to understand exactly what the report shows.
A positive HBsAg result is not enough to decide whether Hepatitis B medicine is required.
A positive anti-HCV result is not enough to confirm current Hepatitis C infection.
Similarly, a viral-load number does not independently reveal how healthy or damaged the liver is.
The right care begins with the correct diagnosis, appropriate liver assessment and a treatment plan based on the actual condition.
For Hepatitis B, the goal is effective viral suppression and prevention of long-term complications.
For Hepatitis C, the goal is virologic cure and management of any existing liver damage.
“हेपेटाइटिस B और C की पॉज़िटिव रिपोर्ट देखकर घबराने की नहीं, सही जाँच और सही इलाज समझने की ज़रूरत है। Hepatitis B को प्रभावी रूप से नियंत्रित किया जा सकता है और Hepatitis C को अधिकांश मरीजों में पूरी तरह ठीक किया जा सकता है।”
Dr. Karan R. Rawat
Gastrointestinal & Hepatobiliary Surgery | Liver, Gallbladder & Pancreatic Conditions
Safe Gastro & Surgery Center, Church Road, Civil Lines, Agra
Medical disclaimer: This educational article does not replace individual medical diagnosis or advice. Antiviral treatment, vaccination, pregnancy-related management and cirrhosis surveillance require personalised evaluation. Severe jaundice, confusion, bleeding or other signs of liver failure require emergency assessment.
Medical and Public Health References
- World Health Organization. Hepatitis B Fact Sheet, July 28, 2026.
- World Health Organization. Hepatitis C Fact Sheet, July 28, 2026.
- WHO. Consolidated Guidance on Hepatitis B and C Prevention, Testing, Treatment, Service Delivery and Monitoring, February 15, 2026.
- WHO. Guidelines for the Prevention, Diagnosis, Care and Treatment for People With Chronic Hepatitis B Infection, 2024.
- AASLD/IDSA. Updated Practice Guideline on Chronic Hepatitis B Treatment, 2025.
- AASLD/IDSA. Recommendations for Testing, Managing and Treating Hepatitis C Virus Infection.
- Centers for Disease Control and Prevention. Clinical Testing and Diagnosis for Hepatitis B.
- Centers for Disease Control and Prevention. Clinical Screening and Diagnosis for Hepatitis C.
- Ministry of Health and Family Welfare, Government of India. National Viral Hepatitis Control Programme.
Final medical review and approval by the named clinician are recommended before website publication.